Gl. Qiao et Kf. Fung, PHARMACOKINETIC-PHARMACODYNAMIC MODELING OF MEPERIDINE IN GOATS .1. PHARMACOKINETICS, Journal of veterinary pharmacology and therapeutics, 16(4), 1993, pp. 426-437
Plasma and cerebrospinal fluid (CSF) pharmacokinetics of meperidine we
re investigated after intramuscular (i.m.) or intravenous (i.v.) admin
istration at a dose of 5 mg/kg in adult goats. After i.m. dosing, the
plasma profile was best described by a one-compartment open model. In
healthy (n = 16) and postoperative (n = 16) goats, the parameters were
, respectively: t(max) 8.3 +/- 3.9 and 9.2 +/- 5.5 min, V-d 2.763 +/-
1.231 and 3.929 +/- 2.101 1/kg, Cl-b, 0.125 +/- 0.036 and 0.087 +/- 0.
025 1/kg/min, K-e 0.0563 +/- 0.0358 and 0.0271 +/- 0.0136 min(-1). The
plasma profile was best fitted by a two-compartment open model follow
ing i.v. injection. In this case, the parameters for healthy (n = 7) a
nd post-operative (n = 13) goats were, respectively: V-d 5.212 +/- 1.9
92 and 5.085 +/- 2.288 1/kg, Cl-b 0.096 +/- 0.028 and 0.075 +/- 0.026
1/kg/min, beta 0.0211 +/- 0.0093 and 0.0160 +/- 0.0052 min.(-1). There
were, however, a few individuals with a prolonged elimination phase.
Bioavailability of i.m. meperidine was 66.5 +/- 15.8% in healthy (n =
6) goats, but much higher in postoperative (n = 10) ones at 94.6 +/- 3
0.0%. Meperidine diffused into and out of CSI; according to a first-or
der rate process. The time-course of CSF drug concentration was simula
ted by a biexponential function. CSF kinetic parameters of i.m. meperi
dine for healthy (n = 7) and postoperative (n = 13) goats were: elimin
ation rate constant (K-ef) 0.0269 +/- 0.0131 and 0.0305 +/- 0.0177 min
(-1), peak CSF concentration time (T-maxf) 15.9 +/- 5.0 and 17.0 +/- 6
.9 min. For the i.v. dosed healthy (n = 6) and postoperative (n = 8) a
nimals, K-ef was 0.0408 +/- 0.0107, 0.0414 +/- 0.0123 min(-1) and T-ma
xf was 10.0 +/- 5.0 and 7.7 +/- 2.5 min, respectively. It was demonstr
ated that an obviously lower peak concentration can be reached signifi
cantly later in CSF than in plasma, and the kinetic behaviour of meper
idine in plasma is different from that in the CSF, indicating meperidi
ne analgesia might not be predicted by simple extrapolation from the k
inetic data.